Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
Cardlytics (CDLX) reported a Q3 loss of $0.15 per share, which was better than the expected loss of $0.33 per share. This is a decline from last year's earnings of $0.01 per share.
November 06, 2024 | 11:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cardlytics reported a Q3 loss of $0.15 per share, better than the expected $0.33 loss, but a decline from last year's $0.01 earnings per share.
Cardlytics' Q3 loss was smaller than expected, which is positive news and could lead to a short-term stock price increase. However, the decline from last year's earnings may temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100